We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Mayne Pharma has announced the launch of LEXETTE (halobetasol propionate) Foam 0.05% in the United States. LEXETTE, the conditionally-acceptable trade name for halobetasol foam is a new formulation of halobetasol...